Here are relevant reports on : india-insurtech-market

  • MarketsandMarkets expects the India Human Capital Management (HCM) in SMB market to grow from USD 133 million in 2018 to USD 214 million by 2022, at a Compound Annual Growth Rate (CAGR) of 12.5% during forecast period. Central government initiatives, such as Make in India, Startup India, and Skill India are expected to drive the India HCM market. Major vendors in the India HCM market include Keka (Hyderabad), Darwinbox (Hyderabad), greytHR (Bengaluru), ZingHR (Mumbai), People Works (Bengaluru), and Zoho (Chennai). These vendors have adopted various growth strategies in the India HCM market.

    • Published: February 2019
    • Price: $ 4950
    • TOC Available:
  • The report covers the Indian bus industry market and is broadly segmented by fuel type (Diesel, CNG/LPG, and others). The market is further segmented by number of axles (Single Axle, Multi Axle), number of seats, comfort level (luxury and non-luxury segment), and region (North, South, East, and West) focusing on key states in each region.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • With the impact on globalization, outsourcing was seen as one of the early impacts. Automotive manufacturing was no alien to this outsourcing phenomenon. China and India, owing to their well-developed infrastructure and easy availability of trained and educated labor at reasonable rates, has become the new hub of global manufacturing for the automotive industry. Almost all the leading automotive car manufacturer have their production base in either of these two countries. To tap these opportunities, a large of auto component manufacturers have opened up their production plants in India and China. This has transformed into a huge multi-billion dollar market and is growing at a steady pace. Our report covers the different categories of automotive manufacturing in India and China and also analyzes the current trends and forecasts. We also have covered in-depth the government regulations towards the outsourcing trend in both the countries.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.

    • Published: April 2010
    • Price: $ 4950
    • TOC Available:
  • The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.

    • Published: July 2010
    • Price: $ 4950
    • TOC Available:
  • With the historic growth rate of more than 8%, the BRIC wine market is expected to grow significantly in the near future due to changing consumer attitudes towards premium alcohols, rising disposable income, and awareness about medical benefits of the wine.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) over the period 2009-2014. The report categorizes the overall market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems.

    • Published: December 2024
    • Price: $ 4950
    • TOC Available:
  • The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.

    • Published: May 2017
    • Price: $ 4950
    • TOC Available:
  • Till recently, companies were targeting the high net worth individuals (those who have invest able assets more than rupees five crore or $1 million); but the focus is now shifting towards Ultra high net worth individuals or families (those who have invest able assets more than rupees 45 crore or $10 million)

    • Published: March 2011
    • Price: $ 4950
    • TOC Available:

Records 1 to 10 of 50

DMCA.com Protection Status